ASX
Chimeric Therapeutics Limited
CHM:ASX•Healthcare
Sensitive ASX Announcement
Fourth dose cohort initiated in CHM 1101 Phase 1 trial
Published: 02/03/23, 12:30pm (AEST)•3 pages